6 194

Cited 0 times in

Interferon β-1b Treatment in a Korean Girl with Multiple Sclerosis

Other Titles
 다발성 경화증 환아에서 Interferon β-1b의 효과적인 치료 증례 
 Hyo Jeong Kim  ;  Heung Dong Kim  ;  Joon Soo Lee  ;  Hoon-Chul Kang 
 Journal of the Korean Child Neurology Society (대한소아신경학회지), Vol.21(1) : 28-32, 2013 
Journal Title
 Journal of the Korean Child Neurology Society (대한소아신경학회지) 
Issue Date
Disease modifying therapies ; Interferon beta-1b ; Multiple sclerosis
Here we report a case of pediatric multiple sclerosis treated with interferon β-1b. Interferon beta is widely used in adult patients with multiple sclerosis (MS). However, its effects and safety in pediatric patients have not been well established. Although supporting data are limited, the use of disease modifying therapies (DMTs) such as interferon β-1b is recommended early in treatment of children with MS. Reports of interferon beta treatment in pediatric MS patients in Korea are rare. In this report, we describe a Korean girl who was effectively treated with interferon β-1b for three years. There were no relapses or serious side effects. Therefore, this report provides evidence supporting the use of interferon beta in pediatric MS patients in Korea and other Asian countries. We also reviewed current medical treatment of MS, including some DMTs and second-line treatment options such as natalizumab and cyclophosphamide, and several new oral agents such as fingolimod.
Full Text
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Hoon Chul(강훈철) ORCID logo https://orcid.org/0000-0002-3659-8847
Kim, Hyo Jeong(김효정)
Kim, Heung Dong(김흥동) ORCID logo https://orcid.org/0000-0002-8031-7336
Lee, Joon Soo(이준수) ORCID logo https://orcid.org/0000-0001-9036-9343
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.